May 9, 2012
Kyowa Medex, a subsidiary of Kyowa Hakko Kirin, launched on May 7 two in vitro diagnostic (IVD) reagents Poteligeo Test IHC and Poteligeo Test FCM used for selecting patients who will respond to Kyowa Kirin’s adult T-cell leukemia-lymphoma (ATL) treatment...read more